Doug Stryke

6.6k total citations · 2 hit papers
33 papers, 3.1k citations indexed

About

Doug Stryke is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Doug Stryke has authored 33 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Doug Stryke's work include Drug Transport and Resistance Mechanisms (17 papers), Metabolism and Genetic Disorders (8 papers) and Amino Acid Enzymes and Metabolism (7 papers). Doug Stryke is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Metabolism and Genetic Disorders (8 papers) and Amino Acid Enzymes and Metabolism (7 papers). Doug Stryke collaborates with scholars based in United States, Japan and Russia. Doug Stryke's co-authors include Thomas E. Ferrin, Kathleen M. Giacomini, Susan J. Johns, Conrad C. Huang, Michiko Kawamoto, Elaine J. Carlson, Scot Federman, Charles Y. Chiu, Samia N. Naccache and Ira Herskowitz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Scientific Reports.

In The Last Decade

Doug Stryke

33 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid

2019 368 citations Steve Miller, Samia N. Naccache et al. Genome Research profile →
Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis

2015 353 citations Alexander L. Greninger, Samia N. Naccache et al. Genome Medicine profile →

Peers

Countries citing papers authored by Doug Stryke

Since Specialization

Citations

This map shows the geographic impact of Doug Stryke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug Stryke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug Stryke more than expected).

Fields of papers citing papers by Doug Stryke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doug Stryke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug Stryke. The network helps show where Doug Stryke may publish in the future.

Co-authorship network of co-authors of Doug Stryke

This figure shows the co-authorship network connecting the top 25 collaborators of Doug Stryke. A scholar is included among the top collaborators of Doug Stryke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doug Stryke. Doug Stryke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	298. Host Response Profiling from Clinical Metagenomic Sequencing Data for Diagnosis of Central Nervous System Infections 2025 ·Open Forum Infectious Diseases ·(unknown), Mikaël de Lorenzi-Tognon, Patrick Benoit, Venice Servellita, (unknown), Noah Brazer, (unknown), Danielle Ingebrigtsen, Jessica Streithorst, Doug Stryke, Kelsey C. Zorn, (unknown), Michael R. Wilson, Charles Y. Chiu	2
2	Longitudinal comparison of the developing gut virome in infants and their mothers 2023 ·Cell Host & Microbe ·William A. Walters, Andrea Granados, Catherine Ley, Scot Federman, Doug Stryke, Yale Santos, Thomas D. Haggerty, Alicia Sotomayor-González, Venice Servellita, Ruth E. Ley, Julie Parsonnet, Charles Y. Chiu	29
3	Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination 2020 ·Scientific Reports ·Susanna K. Tan, Andrea Granados, Jérôme Bouquet, (unknown), Lauri Green, Scot Federman, Doug Stryke, Thomas D. Haggerty, Catherine Ley, Ming Te Yeh, Kaniz Jannat, Yvonne Maldonado, Raul Andino, Julie Parsonnet, Charles Y. Chiu	7
4	Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid breakdown → 2019 ·Genome Research ·Steve Miller, Samia N. Naccache, Erik Samayoa, Kevin Messacar, Shaun Arevalo, Scot Federman, Doug Stryke, Elizabeth Pham, (unknown), William J. Bolosky, Danielle Ingebrigtsen, (unknown), (unknown), John A. D. Leake, Rick L. Pesano, Roberta L. DeBiasi, Samuel R. Dominguez, Charles Y. Chiu	368
5	A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): a retrospective cohort study 2015 ·The Lancet Infectious Diseases ·Alexander L. Greninger, Samia N. Naccache, Kevin Messacar, Anna Marie Clayton, Guixia Yu, Sneha Somasekar, Scot Federman, Doug Stryke, Christopher Anderson, Shigeo Yagi, Sharon Messenger, Debra A. Wadford, Dongxiang Xia, James Watt, Keith Van Haren, Samuel R. Dominguez, Carol Glaser, Grace M. Aldrovandi, Charles Y. Chiu	280
6	Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis breakdown → 2015 ·Genome Medicine ·Alexander L. Greninger, Samia N. Naccache, Scot Federman, Guixia Yu, Placide Mbala, Vanessa Brès, Doug Stryke, Jérôme Bouquet, Sneha Somasekar, Jeffrey M. Linnen, Roger Y. Dodd, Prime Mulembakani, Bradley S. Schneider, Jean‐Jacques Muyembé‐Tamfum, Susan L. Stramer, Charles Y. Chiu	353
7	The Structure–Function Linkage Database 2013 ·Nucleic Acids Research ·Eyal Akiva, Shoshana Brown, Daniel E. Almonacid, Alan E. Barber, (unknown), Michael Hicks, Conrad C. Huang, (unknown), Susan T. Mashiyama, Elaine C. Meng, (unknown), John H. Morris, Sunil Ojha, Alexandra M. Schnoes, Doug Stryke, Jeffrey M. Yunes, Thomas E. Ferrin, Gemma L. Holliday, Patricia C. Babbitt	189
8	Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3 2012 ·The Pharmacogenomics Journal ·(unknown), (unknown), (unknown), Sook Wah Yee, Lijun Xu, (unknown), Congcong Wen, Kazuhiko Fujii, Susan J. Johns, Doug Stryke, Thomas E. Ferrin, Jeffry Simko, (unknown), J. F. Costello, Kathleen M. Giacomini	67
9	Functional Characterization of Liver Enhancers That Regulate Drug-Associated Transporters 2011 ·Clinical Pharmacology & Therapeutics ·Myeong‐Jin Kim, Peter Skewes-Cox, (unknown), Stephanie Hesselson, Sook Wah Yee, Laura B. Ramsey, Loan Nguyen, (unknown), R A Castro, (unknown), Doug Stryke, Susan J. Johns, Thomas E. Ferrin, Pui–Yan Kwok, MV Relling, Kathleen M. Giacomini, Deanna L. Kroetz, Nadav Ahituv	18
10	Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1 2009 ·Pharmacogenetics and Genomics ·Ji Ha Choi, Sook Wah Yee, Mee J. Kim, Loan Nguyen, Jeong Ho Lee, Ji‐One Kang, Stephanie Hesselson, Richard A. Castro, Doug Stryke, Susan J. Johns, Pui–Yan Kwok, Thomas E. Ferrin, Min Goo Lee, (unknown), Nadav Ahituv, Kathleen M. Giacomini	45
11	The Human Multidrug Resistance Protein 4 (MRP4, ABCC4): Functional Analysis of a Highly Polymorphic Gene 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Nada Abla, Leslie W. Chinn, Tsutomu Nakamura, Li Liu, Conrad C. Huang, Susan J. Johns, Michiko Kawamoto, Doug Stryke, Travis R. Taylor, Thomas E. Ferrin, Kathleen M. Giacomini, Deanna L. Kroetz	88
12	Identification and Characterization of Proximal Promoter Polymorphisms in the Human Concentrative Nucleoside Transporter 2 (SLC28A2) 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Sook Wah Yee, James E. Shima, Stephanie Hesselson, Loan Nguyen, Sarah De Val, (unknown), Michiko Kawamoto, Susan J. Johns, Doug Stryke, Pui–Yan Kwok, Thomas E. Ferrin, Brian L. Black, David Gurwitz, Nadav Ahituv, Kathleen M. Giacomini	23
13	PharmGKB Submission Update: VI. PMT Submissions of Genetic Variations in Neurotransmitter Transporters (SLC6, SLC17, and SLC18) to the PharmGKB Network 2006 ·Pharmacological Reviews ·Ilaria Badagnani, Marco D. Sorani, Robert H. Edwards, Chaline Brown, Richard A. Castro, Conrad C. Huang, Doug Stryke, Michiko Kawamoto, Susan J. Johns, Elaine J. Carlson, Travis R. Taylor, (unknown), Melanie de la Cruz, Thomas E. Ferrin, Esteban G. Burchard, Ira Herskowitz, Deanna L. Kroetz, Kathleen M. Giacomini	2
14	PharmGKB Submission Update: IV. PMT Submissions of Genetic Variations in ATP-Binding Cassette Transporters to the PharmGKB Network 2006 ·Pharmacological Reviews ·(unknown), Jason M. Gow, Leslie W. Chinn, Libusha Kelly, (unknown), Conrad C. Huang, Doug Stryke, Michiko Kawamoto, Susan J. Johns, Elaine J. Carlson, Travis R. Taylor, Thomas E. Ferrin, Andrej Săli, Kathleen M. Giacomini, Deanna L. Kroetz	15
15	Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2 2005 ·Pharmacogenetics and Genomics ·Ryan Owen, Jennifer H. Gray, Travis R. Taylor, Elaine J. Carlson, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin, Kathleen M. Giacomini	42
16	FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2 2005 ·Drug Metabolism and Disposition ·Ryan Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie de la Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin, Kathleen M. Giacomini	30
17	Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1) 2005 ·Pharmacogenetics and Genomics ·Tomoe Fujita, Chaline Brown, Elaine J. Carlson, Travis R. Taylor, Melanie de la Cruz, Susan J. Johns, Doug Stryke, Michiko Kawamoto, Kazumi Fujita, Richard A. Castro, Chung-Wen Chen, Emil T. Lin, Claire M. Brett, Esteban G. Burchard, Thomas E. Ferrin, Conrad C. Huang, Maya K. Leabman, Kathleen M. Giacomini	81
18	PharmGKB Update: III. Genetic Variants of SLC22A1, Solute Carrier Family 22 (Organic Cation Transporter), Member 1 2004 ·Pharmacological Reviews ·Yan Shu, Maya K. Leabman, Bo Feng, Lara M. Mangravite, Conrad C. Huang, Doug Stryke, Michiko Kawamoto, Susan J. Johns, Joseph DeYoung, Elaine J. Carlson, Thomas E. Ferrin, Ira Herskowitz, Kathleen M. Giacomini	4
19	BayGenomics: a resource of insertional mutations in mouse embryonic stem cells 2003 ·Nucleic Acids Research ·Doug Stryke	197
20	Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene 2003 ·Pharmacogenetics ·Deanna L. Kroetz, Christiane Pauli‐Magnus, Laura M. Hodges, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin, Joseph DeYoung, Travis R. Taylor, Elaine J. Carlson, Ira Herskowitz, Kathleen M. Giacomini, Andrew G. Clark	352

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact